Compare ImmunityBio Inc. Common Stock (IBRX) vs Ingersoll Rand (IR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ImmunityBio Inc. Common Stock vs Ingersoll Rand — how do they compare? ImmunityBio Inc. Common Stock trades at $9.98 (market cap $10.51B), while Ingersoll Rand trades at $78.16 (market cap $30.26B). The key difference: Ingersoll Rand is far larger — about 2.9× ImmunityBio Inc. Common Stock's market cap, and Ingersoll Rand pays a 0.1% dividend while ImmunityBio Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold ImmunityBio Inc. Common Stock for 0 Days and Ingersoll Rand for 7 Days on average.
| IBRX | IR | |
|---|---|---|
Market Cap | $10.51B | $30.26B |
Volume | 10,445,785 | 4,017,622 |
Sector | Health | Industrials |
52-Week High | $11.55 | $98.76 |
52-Week Low | $1.98 | $68.54 |
Typical Hold Time | 0 Days | 7 Days |
Enterprise Value | $10.97B | $33.92B |
Dividend Yield | — | 0.1% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About ImmunityBio Inc. Common Stock
ImmunityBio develops immune-based therapies for cancer and infectious diseases. Its programs are designed to activate and strengthen the body’s immune response.
Read more on IBRX →About Ingersoll Rand
Ingersoll Rand develops industrial technologies for creating and managing flow, pressure, and motion. Its portfolio includes compressors, pumps, vacuum systems, and other equipment used across industrial markets.
Read more on IR →
